The tick-over theory revisited: is C3 a contact-activated protein?
- PMID: 22964236
- DOI: 10.1016/j.imbio.2012.07.008
The tick-over theory revisited: is C3 a contact-activated protein?
Abstract
The tick-over theory was first introduced in the 1970s to explain the presence of the initial C3b molecules, which are able to trigger complement activation by the alternative pathway in human plasma under physiological conditions. After the identification of the thioester, the predominant hypothesis has been that this bond is hydrolyzed at a slow but constant rate by nucleophilic attack by H(2)O, leading to the generation of C3(H(2)O). Here we put forward the hypothesis that the rate of hydrolysis of C3 to C3(H(2)O) may be greatly accelerated by the interaction between C3 and a number of biological and artificial interfaces, including gas bubbles, biomaterial surfaces and different lipid surfaces and complexes. We therefore propose that C3 should preferentially be regarded as a contact activated protein rather than a target for passive, random hydrolysis in the fluid phase.
Copyright © 2012 Elsevier GmbH. All rights reserved.
Similar articles
-
Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.J Immunol. 1999 Jun 15;162(12):7426-33. J Immunol. 1999. PMID: 10358196
-
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.J Exp Med. 1981 Sep 1;154(3):856-67. doi: 10.1084/jem.154.3.856. J Exp Med. 1981. PMID: 6912277 Free PMC article.
-
Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3.Ann N Y Acad Sci. 1983;421:291-8. doi: 10.1111/j.1749-6632.1983.tb18116.x. Ann N Y Acad Sci. 1983. PMID: 6586103
-
The human alternative complement pathway: biology and immunopathology of activation and regulation.Prog Allergy. 1982;30:193-234. Prog Allergy. 1982. PMID: 7041132 Review. No abstract available.
-
[Proteases in complement system (author's transl)].Tanpakushitsu Kakusan Koso. 1980;25(6):531-46. Tanpakushitsu Kakusan Koso. 1980. PMID: 7010425 Review. Japanese. No abstract available.
Cited by
-
Microbial evasion of the complement system: a continuous and evolving story.Front Immunol. 2024 Jan 4;14:1281096. doi: 10.3389/fimmu.2023.1281096. eCollection 2023. Front Immunol. 2024. PMID: 38239357 Free PMC article. Review.
-
Sex and species associated differences in Complement-mediated immunity in Humans and Rhesus macaques.bioRxiv [Preprint]. 2023 Oct 25:2023.10.23.563614. doi: 10.1101/2023.10.23.563614. bioRxiv. 2023. PMID: 37961263 Free PMC article. Updated. Preprint.
-
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.Drugs. 2023 Nov;83(16):1475-1499. doi: 10.1007/s40265-023-01940-2. Epub 2023 Sep 25. Drugs. 2023. PMID: 37747686 Free PMC article. Review.
-
Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review.Diagnostics (Basel). 2023 Jul 10;13(14):2328. doi: 10.3390/diagnostics13142328. Diagnostics (Basel). 2023. PMID: 37510072 Free PMC article. Review.
-
Complement therapeutics are coming of age in rheumatology.Nat Rev Rheumatol. 2023 Aug;19(8):470-485. doi: 10.1038/s41584-023-00981-x. Epub 2023 Jun 19. Nat Rev Rheumatol. 2023. PMID: 37337038 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
